Drug Type Small molecule drug |
Synonyms Toc Trip Powder, 톡트립산 |
Target |
Action antagonists, inhibitors |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists), PARP1 inhibitors(Poly (ADP-Ribose) polymerase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (14 Apr 2025), |
Regulation- |
Molecular FormulaC17H20N4O6 |
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N |
CAS Registry83-88-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Motion Sickness | South Korea | 14 Apr 2025 |